Cargando…
Pharmacogenetics of Parkinson’s Disease – Through Mechanisms of Drug Actions
In the last years due to development of molecular methods a substantial progress in understanding of genetic associations with drug effects in many clinical disciplines has been observed. The efforts to define the role of genetic polymorphisms in optimizing pharmacotherapy of Parkinson’s disease (PD...
Autores principales: | Droździk, Marek, Białecka, Monika, Kurzawski, Mateusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924251/ https://www.ncbi.nlm.nih.gov/pubmed/24532988 http://dx.doi.org/10.2174/1389202914666131210212521 |
Ejemplares similares
-
Analysis of selected genetic variants in psoriasis susceptibility and response to treatment
por: Malinowski, Damian, et al.
Publicado: (2022) -
A Possible Role for HMG-CoA Reductase Inhibitors and Its Association with HMGCR Genetic Variation in Parkinson’s Disease
por: Pierzchlińska, Anna, et al.
Publicado: (2021) -
Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease
por: von Otter, Malin, et al.
Publicado: (2010) -
Influence of variation in the catechol-O-methyltransferase gene on the clinical outcome after lumbar spine surgery for one-level symptomatic disc disease: a report on 176 cases
por: Rut, Marcin, et al.
Publicado: (2013) -
Arterial Blood Pressure Variability and Other Vascular Factors Contribution to the Cognitive Decline in Parkinson’s Disease
por: Pierzchlińska, Anna, et al.
Publicado: (2021)